undamentalytics Newsletter
Sign in

Biocardia, Inc. balance sheet

At the end of fiscal 2025, Biocardia, Inc. had total assets of $3.4m, total liabilities of $2.5m and shareholders' equity of $895,000. It held $2.5m in cash against $0 of debt: net cash of $2.5m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Dec 20102011Dec 20112015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Cash and equivalents013421135621137122
Receivables0000000000000
Inventory——10000——————
Total current assets114522136623138133
Total assets5145221468231610343
Accounts payable—011111111101
Deferred revenue (current)——000001100——
Total current liabilities——81234444422
Total debt0060000100000
Total liabilities2182235455533
Shareholders' equity313−321114219105−211
Net debt (negative = net cash)−0−132−21−13−5−6−21−13−7−1−2−2

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Biocardia, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Biocardia, Inc.